Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
Frequently asked questions
What sector does Braxia Scientific Corp (BRAX) operate in?
Braxia Scientific Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Braxia Scientific Corp (BRAX) current stock price?
As of the latest data, Braxia Scientific Corp stock price is CA$0.01, with a previous close of CA$0.01.
What is Braxia Scientific Corp (BRAX) current market capitalization?
Braxia Scientific Corp market cap is approximately 1.42 million.
What is Braxia Scientific Corp (BRAX) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.05.
Does Braxia Scientific Corp (BRAX) pay dividends?
No. Braxia Scientific Corp does not pay a dividend.
What is Braxia Scientific Corp (BRAX) beta (volatility) score?
Braxia Scientific Corp has a beta of 1.452, suggesting it is more volatile than the market.
